...
首页> 外文期刊>Microbes and infection >Recombinant Mycobacterium bovis BCG expressing chimaeric protein of Ag85B and ESAT-6 enhances immunostimulatory activity of human macrophages.
【24h】

Recombinant Mycobacterium bovis BCG expressing chimaeric protein of Ag85B and ESAT-6 enhances immunostimulatory activity of human macrophages.

机译:表达嵌合蛋白Ag85B和ESAT-6的牛分枝杆菌重组BCG可增强人巨噬细胞的免疫刺激活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Recombinant BCG strain that secretes the chimaeric protein of Ag85B and ESAT-6 has been demonstrated to augment Th1 immune response in C57BL/6 mice. In this paper, we studied the immunostimulatory activity of the recombinant BCG strains in vitro and found out that rBCG-A(N)-E-A(C) activated THP-1 cells and induced higher expression levels of CD86, CD80, CD40 and HLA-DR, especially increased the ratio of CD86/CD80. Likewise, rBCG-A(N)-E-A(C) infection was able to stimulate an increase in TNF-alpha production of macrophages. Moreover, rBCG-A(N)-E-A(C) up-regulated the expression of EFHD2, ACTB and ACTG1 in the macrophages and improved the ability of antigen presentation and the CD8(+) T-cells immune response. Taken together, this rBCG-A(N)-E-A(C) strain enhanced the immunostimulatory activity of human macrophages and could be a potential vaccine against Mycobacterium tuberculosis.
机译:业已证明,分泌Ag85B和ESAT-6嵌合蛋白的重组BCG菌株可增强C57BL / 6小鼠的Th1免疫应答。在本文中,我们研究了重组BCG菌株的体外免疫刺激活性,发现rBCG-A(N)-EA(C)激活了THP-1细胞并诱导了较高的CD86,CD80,CD40和HLA-表达水平。 DR尤其增加了CD86 / CD80的比率。同样,rBCG-A(N)-E-A(C)感染能够刺激巨噬细胞的TNF-α产生增加。此外,rBCG-A(N)-E-A(C)上调了巨噬细胞中EFHD2,ACTB和ACTG1的表达,并提高了抗原呈递和CD8(+)T细胞免疫反应的能力。两者合计,这种rBCG-A(N)-E-A(C)菌株增强了人类巨噬细胞的免疫刺激活性,并且可能是抗结核分枝杆菌的潜在疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号